Clinical Trial Update: To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating immunogenicity and safety of an inactivated Hepatitis A vaccine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• Inactivated hepatitis A vaccine (Hepatitis A vaccine, inactivated)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Hepatitis A Vaccine | Phase 3 | Status: COMPLETED